Covered versus uncovered self-expandable nitinol stents in the palliative treatment of malignant distal biliary obstruction: results from a randomized, multicenter study

Eric Kullman, Farshad Frozanpor, Claes Soderlund, Stefan Linder, Per Sandstrom, Anna Lindhoff-Larsson, Ervin Toth, Gert Lindell, Eduard Jonas, Jacob Freedman, Martin Ljungman, Claes Rudberg, Bo Ohlin, Rebecka Zacharias, Carl-Eric Leijonmarck, Kalev Teder, Anders Ringman, Gunnar Persson, Mehmet Gozen, Olle Eriksson

Forskningsoutput: Kapitel i bok/rapport/Conference proceedingKonferenspaper i proceedingPeer review

Sammanfattning

Background: Covered biliary metal stents have been developed to prevent tumor ingrowth. Previous comparative studies are limited and often include few patients. Objective: To compare differences in stent patency, patient survival, and complication rates between covered and uncovered nitinol stents in patients with malignant biliary obstruction. Design: Randomized, multicenter trial conducted between January 2006 and October 2008. Setting: Ten sites serving a total catchment area of approximately 2.8 million inhabitants. Patients: A total of 400 patients with unresectable distal malignant biliary obstruction. Interventions: ERCP with insertion of covered or uncovered metal stent. Follow-up conducted monthly for symptoms indicating stent obstruction. Main Outcome Measurements: Time to stent failure, survival time, and complication rate. Results: The patient survival times were 116 days (interquartile range 242 days) and 174 days (interquartile range 284 days) in the covered and uncovered stent groups, respectively (P = .320). The first quartile stent patency time was 154 days in the covered stent group and 199 days in the uncovered stent group (P = .326). There was no difference in the incidence of pancreatitis or cholecystitis between the 2 groups. Stent migration occurred in 6 patients (3%) in the covered group and in no patients in the uncovered group (P = .030). Limitations: Randomization was not blinded. Conclusions: There were no significant differences in stent patency time, patient survival time, or complication rates between covered and uncovered nitinol metal stents in the palliative treatment of malignant distal biliary obstruction. However, covered stents migrated significantly more often compared with uncovered stents, and tumor ingrowth was more frequent in uncovered stents. (Clinical trial registration number: NCT00280709.) (Gastrointest Endosc 2010;72:915-23.)
Originalspråkengelska
Titel på värdpublikationGastrointestinal Endoscopy
FörlagElsevier
Sidor915-923
Volym72
DOI
StatusPublished - 2010
EvenemangDigestive Disease Week/110th Annual Meeting of the American-Gastroenterological-Association - Chicago, IL
Varaktighet: 2009 maj 302009 juni 4

Publikationsserier

Namn
Nummer5
Volym72
ISSN (tryckt)0016-5107

Konferens

KonferensDigestive Disease Week/110th Annual Meeting of the American-Gastroenterological-Association
Period2009/05/302009/06/04

Bibliografisk information

The information about affiliations in this record was updated in December 2015.
The record was previously connected to the following departments: Surgery (Lund) (013009000), Emergency medicine/Medicine/Surgery (013240200)

Ämnesklassifikation (UKÄ)

  • Kirurgi
  • Klinisk medicin

Fingeravtryck

Utforska forskningsämnen för ”Covered versus uncovered self-expandable nitinol stents in the palliative treatment of malignant distal biliary obstruction: results from a randomized, multicenter study”. Tillsammans bildar de ett unikt fingeravtryck.

Citera det här